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Background: Alcohol dependence displays a wide variety of clinical phenotypes. Various 
typology classifications of alcoholism include age of onset of alcohol abuse as one of the major 
phenotypic features. Serotonergic changes have been associated with alcoholism, while serotonin 
receptors type 1B (5-HT1B) play an important role in regulating serotonergic neurotransmission. 
The rs13212041 polymorphism modulates the expression of HTR1B gene coding for 5-HT1B 
receptor. This study examined the association of platelet serotonin (5-HT) and HTR1B gene 
with the onset of alcohol abuse in alcohol-dependent subjects.
Materials and methods: Determination of platelet 5-HT concentration and genotyping of 
rs13212041 HTR1B gene polymorphism were performed in 613 alcohol-dependent patients, 
subdivided according to early/late onset (before/after 25 years of age) of alcohol abuse.
Results: Alcohol-dependent individuals with CC genotype were more frequent in the group 
with early onset of alcohol abuse compared to carriers of T allele. Besides HTR1B genotype, 
age and gender, but not platelet 5-HT, were major variables associated with the onset of alcohol 
abuse. Platelet 5-HT concentration was not significantly different between patients with early 
and late onset of alcohol abuse, or patients carrying various HTR1B genotypes. Although we 
observed no influence of co-variables such as age, gender, or somatic and psychiatric comor-
bidities, platelet 5-HT concentration was significantly affected by smoking.
Conclusion: These findings support potential involvement of 5-HT1B receptors in the onset 
of alcohol abuse and development of alcohol dependence. Additionally, the results of our study 
emphasize the importance of controlling for smoking status, as one of the significant confound-
ing factors influencing platelet 5-HT concentration.
Keywords: alcoholism, age of onset, 5-HT1B, gene variants, platelet serotonin, smoking
Introduction
Patients with alcohol dependence display individual differences in clinical symptoms 
and phenotypic characteristics, including disease severity, course and prognosis, 
comorbidity, and treatment response, which may be the result of different underlying 
neurobiological mechanisms, such as genetic and environmental influences.1,2 In 
order to reduce the heterogeneity of this complex disease, different authors proposed 
various typology classifications to divide alcohol-dependent subjects into more 
specific subtypes or endophenotypes.3 Many proposed classifications of alcohol 
dependence include the age of onset of alcohol abuse as one of the major phenotypic 
features with potential usefulness in elucidating underlying neurobiological pathways 
and improvement of the therapy.4,5 The age of onset of alcohol abuse might be due 
to the individual’s genetic predisposition, as well as to a number of environmental 
factors.6 The Cloninger classification,7 among the most widely used classification 
schemes for alcohol dependence,8 also uses onset of alcohol abuse to differentiate 
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between alcohol-dependent subjects type I and II, which 
differ in the course of the disease, extent of inheritance, and 
personality traits.9
Subjects with an early onset (before 25 years of age) of 
alcohol abuse (type II alcoholism) are more likely to drink 
heavily, to have more alcohol-related problems, more severe 
symptoms, and higher rates of somatic and psychiatric 
comorbidity.4,10 In addition, early onset alcoholism has been 
often associated with elevated levels of antisocial behavior 
and delinquency during adolescence and characterized as 
strongly heritable and male-limited.7 These subjects use 
alcohol for its euphoric effects and demonstrate high novelty 
seeking and low harm-avoidance personality traits.11 On the 
other hand, type I alcoholics have later onset of alcohol abuse 
(after 25 years of age) and are more strongly influenced by 
social environmental factors. Moreover, alcoholism with 
later onset affects both men and women, who drink alcohol 
for its anxiolytic properties and have high harm-avoidance 
personality traits.7 These two subtypes of alcohol-dependence 
are suggested to have different neurobiological backgrounds. 
Namely, it has been proposed that type I and type II alcohol-
dependent individuals, differing in the age of alcoholism 
onset, have a deficit in the dopaminergic or serotonergic 
neurotransmission, respectively.12 This has been supported 
by studies demonstrating that type II alcoholics seem to have 
reduced levels of serotonin transporter (5-HTT) already in 
early age, whereas in type I alcoholics, the serotonergic 
alterations may be secondary and possibly reflecting the 
alterations in the dopaminergic system.13,14
Variations in the 5-HTT gene15 and tryptophan hydroxy-
lase gene16 have been associated with an increased risk of 
alcohol dependence with an early onset as well as with 
alcohol treatment response.17 Moreover, decreased seroto-
nergic neurotransmission18 and reduced concentrations of 
5-hydroxyindoleacetic acid (5-HIAA), the major metabolite 
of serotonin (5-HT), have been found in the cerebrospinal 
fluid of early onset alcohol-dependent subjects.19 Low plasma 
ratio of tryptophan to large neutral amino acids (TRYP/
LNAA ratio), a marker of serotonergic function, has also 
been observed in patients with an early onset of alcohol 
dependence.20 The findings suggest that these individuals 
might have a preexisting 5-HT deficit and therefore increased 
vulnerability to fluctuations in precursor availability, lead-
ing to higher alcohol intake early in life.10 In line with these 
results, low activity of monoamine oxidase (MAO), the 
enzyme degrading 5-HT, has been associated with type II 
subtype of alcoholism.21 In addition, the classification based 
on the age of onset of alcohol abuse seems to be an effective 
predictor of treatment response to various serotonergic 
drugs.22 Namely, ondansetron has been useful in therapy of 
early onset alcoholic patients,23 whereas sertraline has shown 
positive effects in the late onset alcohol-dependent subjects.24 
Conversely, fluoxetine reduced the beneficial effects of 
cognitive–behavioral therapy in early onset alcoholics.25
The involvement of 5-HT system in the onset-based 
alcoholism typologies has been supported by both animal and 
human studies demonstrating that serotonergic disturbances 
have been closely related to reduced inhibitory control of 
behavior, including extensive alcohol use.10,26 Low central 
serotonergic activity has been mostly associated with 
increased alcohol consumption and alcohol dependence.26 
Central 5-HT type 1B (5-HT1B) receptors have an impor-
tant role in the physiologic synaptic feedback mechanism 
and regulation of serotonergic neurotransmission27 and are 
involved in various neurological disorders such as migraine.28 
Moreover, 5-HT1B receptors have been suggested to modu-
late the activity of dopaminergic neurons in the ventral teg-
mental area, which is involved in the reward mechanisms 
underlying addictions, including alcohol dependence.29 
Various animal studies have also implicated 5-HT1B receptor 
in the control of alcohol preference and consumption.30,31
Previous human studies reported the associations between 
different polymorphisms in the gene coding for 5-HT1B 
receptor (HTR1B) and alcohol dependence,32,33 especially 
alcoholism with early onset and antisocial behavior.4,34,35 
The majority of reports assessing the association of HTR1B 
gene and alcoholism investigated G-861C polymorphism,33,34 
which is in strong linkage disequilibrium with other 
functional polymorphisms in the HTR1B gene promoter, such 
as T-261G, A-161T, and C-129T.33,36,37 On the other hand, 
other authors failed to confirm these findings,37–39 perhaps due 
to the variability of alcohol-dependent phenotypes. However, 
only few studies investigated rs13212041 polymorphism, 
shown to modulate HTRIB gene expression,40 and its role in 
alcohol dependence.41,42
As the majority of peripheral 5-HT is stored in platelets, 
which possess many other components of serotonergic sys-
tem, including 5-HTT, MAO-B as well as 5-HT1A, 5-HT2A, 
5-HT3A, and 5-HT4 receptors,43–48 platelets are suggested as 
a limited peripheral model of central serotonergic functions.49 
Moreover, some reports indicated that human platelets also 
contain 5-HT1B receptors,50 although their function in plate-
lets is not known. However, since upon activation, platelets 
release 5-HT into circulation,51 one might speculate that simi-
lar to its role in the brain, platelet 5-HT1B receptors might 
regulate 5-HT levels at the periphery. It is generally accepted 
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that serotonergic components in both platelets and neurons 
are encoded by the same genes and have similar structural 
and functional properties.52,53 Hence, the rs13212041 HTR1B 
gene polymorphism via its influence on the 5-HT1B recep-
tor expression might subsequently affect central as well as 
peripheral 5-HT turnover.
In order to investigate potential changes in the serotoner-
gic activity associated with different alcoholism subtypes, the 
aim of this study was to examine the association of platelet 
5-HT and rs13212041 HTR1B gene polymorphism, with 
the early/late onset of alcohol abuse in alcohol-dependent 
subjects. To our knowledge, this is first such study, with 
appropriate sample size and carefully determined alcohol-
related phenotypes, including possible confounding factors. 
The findings of our study might provide novel insights in the 
serotonergic regulation mechanisms underlying the early/late 
onset of alcohol abuse, which could help in further differen-
tiation of alcoholism subtypes and potential improvement of 
the therapy for this complex disease.
Materials and methods
subjects
The study enrolled 613 medication-free patients (499 males 
and 114 females) with alcohol dependence, recruited from 
the Center of Alcoholism and Other Addictions, University 
Psychiatric Hospital Vrapce, Zagreb, Croatia. Patients with 
alcohol dependence were admitted to hospital due to acute 
intoxication or alcohol-related withdrawal symptoms, and 
were left overnight to sober up. Demographic and clinical 
characteristics of the alcohol-dependent patients are listed in 
Table 1. The alcohol dependence as well as comorbid psy-
chiatric disorders were diagnosed using a structured clinical 
interview (SCID), based on the DSM-IV criteria.54 If alcohol-
dependent patients had any other comorbid substance abuse 
or dependence (except nicotine addiction) or had used any 
kind of drugs in the previous 12 months, they were excluded 
from the study. The alcohol-dependent patients were divided 
according to the onset of alcohol abuse into subjects with early 
(before 25 years of age) and late (after 25 years of age) onset 
of alcohol abuse.7 The data regarding somatic history, includ-
ing current somatic complaints, were collected from hospital 
medical records and obtained by an interview. Participants 
were Caucasians of the European origin from Zagreb County, 
Croatia, and they all agreed to give a blood sample, participate 
in the study, and gave their written informed consent. The 
study was approved by the Ethics Committee of University 
Psychiatric Hospital Vrapce, Zagreb, Croatia and car-
ried out in accordance with the Helsinki Declaration (1964).
Blood collection and processing
The samples of blood (8 mL) from alcohol-dependent patients 
were collected in the morning after overnight fasting by using 
a plastic syringe containing 2 mL anticoagulant (acid citrate 
dextrose). The whole blood was centrifuged at 1100 g for 
3 minutes at 4°C. Obtained platelet-rich plasma was further 
centrifuged at 5087 g for 15 minutes, 4°C to sediment the 
platelets. The platelet pellet was washed with saline and 
centrifuged again. The obtained pellet was stored at -20°C.
Table 1 The demographic and clinical characteristics of alcohol-dependent patients
Alcohol-dependent patients Patients with early 
onset of alcohol abuse 
215 (35.07%)
Patients with late 
onset of alcohol abuse 
398 (64.93%)
Total 613 
(100.00%)
Statistics
age (years) mean ± sD 45.12±10.09 52.33±9.46 49.80±10.27 t=8.79, df =611, P,0.0001; 
student’s t-test
smokers, N (%) 145 (67.44%) 225 (56.53%) 370 (60.36%) χ2=6.943, df =1, P=0.0084; χ2-test
Nonsmokers, N (%) 70 (32.56%) 173 (43.47%) 243 (39.64%)
Males, N (%) 193 (38.68%) 306 (61.32%) 499 (81.40%) χ2=15.30, df =1, P,0.0001; 
χ2-testFemales, N (%) 22 (19.30%) 92 (80.70%) 114 (18.60%)
Patients with somatic 
comorbidities, N (%)
128 (59.53%) 267 (67.08%) 395 (64.44%) χ2=3.473, df =1, P=0.0624; χ2-test
Patients with liver disease, N (%) 125 (58.14%) 261 (65.58%) 386 (62.97%) χ2=3.312, df =1, P=0.0688; χ2-test
Patients with psychiatric 
comorbidities, N (%)
112 (52.09%) 167 (41.96%) 279 (45.51%) χ2=5.780, df =1, P=0.0162; χ2-test
Patients with depression, N (%) 10 (4.65%) 24 (6.03%) 34 (5.55%) χ2=0.5067, df =1, P=0.4766; 
χ2-test
Platelet 5-hT concentration  
(nmol/mg protein) mean ± sD
0.88±0.48 0.79±0.48 0.82±0.48 U=38035, df =611, P=0.023; 
Mann–Whitney test
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Platelet 5-hT measurement
Platelet 5-HT concentration was measured by the spectro-
fluorometric method.55 Briefly, platelets were broken down 
by sonication. Specimens of standard, blank (water), and 
platelet sonicates were analyzed in duplicates. All samples 
were deproteinized with 10% ZnSO
4
 and 1N NaOH, and 
then 0.1% L-cysteine and 0.05% ortho-phthalaldehyde were 
added for the preparation of fluorophore. The 5-HT fluores-
cence was measured on a Varian Spectrophotofluorimeter 
Cary Eclipse (Varian Optical Spectroscopy Instruments, 
Mulgrave, VIC, Australia) (exciting wavelength: 345 nm; 
emitted wavelength: 485 nm). Protein concentrations in 
platelets were determined by the method of Lowry et al.56
genotyping
Genomic DNA was isolated from peripheral blood leukocytes 
by a salting out method.57 Genotyping was performed accord-
ing to the procedure described by Applied Biosystems, using 
TaqMan-based allele-specific polymerase chain reaction on 
ABI Prism 7000 Sequencing Detection System apparatus. 
The rs13212041 (C__32252506_10) single nucleotide 
polymorphism in the HTR1B gene, located on chromosome 
6, was analyzed. Briefly, 20 ng of genomic DNA was PCR 
amplified in 96-well plates using a 10 µL reaction volume. 
The conditions of PCR reaction were: 40 cycles at 92°C for 
15 seconds and 60°C for 60 seconds.
Data analyses
Statistical analyses were performed with GraphPad Prism 
version 4.00 for Windows (GraphPad Software, Inc., San 
Diego, CA, USA) and MedCalc Statistical Software version 
14.8.1 (MedCalc Software bvba, Ostend, Belgium). Normal-
ity of distribution was assessed with the D’Agostino–Pearson 
omnibus normality test. Age of male and female subjects 
enrolled in the study was compared using Student’s t-test. 
The frequency of smoking and early/late onset of alcohol 
abuse between male and female alcohol-dependent patients 
was evaluated by a chi-squared test of independence. Plate-
let 5-HT concentrations were analyzed by Kruskal–Wallis 
test followed by Dunn’s multiple comparison test or with 
Mann–Whitney test, as normality of the data failed. Possible 
deviations from Hardy–Weinberg equilibrium (HWE) were 
tested using goodness of fit chi-squared test. Genotype and 
allele frequencies (presented as numbers and percentages) 
were evaluated by a chi-squared test of independence. Mul-
tiple regression analysis assessed the influence of various 
demographic and clinical data (independent variables), such 
as age, gender, smoking, somatic and psychiatric comorbidi-
ties, on alcohol abuse onset and platelet 5-HT concentration 
(dependent variables).
G*Power 3 Software58 was used for conducting power 
analyses, ie, to determine a priori sample size and to post hoc 
compute the achieved power. For F test (Kruskal–Wallis test) 
involving three groups (with α=0.025; power =0.80; a small 
effect size =0.30), total desired sample size was 132. For F test 
(Kruskal–Wallis test), evaluating four groups (with α=0.025; 
power =0.80; a small effect size =0.30), total desired sample 
size was 152. For Mann–Whitney test (with α=0.025; power 
=0.80; a median effect size =0.30), total desired sample size 
was 368. For analyses with a χ2-test (with α=0.025; power 
(1-β)=0.80 and a small effect size (ω=0.20)), for df =2 total 
desired sample size was 288, and for df =1, total desired sample 
size was 238. As the actual total sample size was 613, the power 
analysis revealed that the study included appropriate sample 
size and statistical power to detect significant differences.
Results
Alcohol-dependent participants were predominantly male 
(81.40%). The group of female subjects with alcohol 
dependence (51.89±11.62) was significantly older (t=2.42, 
df =611, P=0.016; Student’s t-test) than the group of male 
patients (49.32±9.89). There were no significant differences 
in frequency of smoking (χ2=2.01, df =1, P=0.148) between 
male (61.72%) and female (54.39%) alcohol-dependent 
patients. Our study demonstrated that 395 (64.44%) of 
alcohol-dependent patients (67.13% of males and 52.63% of 
females) had some somatic comorbidity, with liver diseases 
present in 386 (62.97%) of enrolled subjects. Hence, most 
(92.72%) somatic diseases in subjects with alcoholism were 
liver diseases. Moreover, 279 (45.51%) alcohol-dependent 
patients, ie, 223 (44.69%) males and 56 (49.12%) females 
reported some psychiatric comorbidity. These psychiatric 
comorbidities include personality disorders (49.10%), stress-
related disorders (37.27%) including anxiety, acute stress 
reaction and post-traumatic stress disorder, mood disorders 
(12.19%) primarily depression, and psychotic disorders such 
as schizophrenia (1.43%). There were no significant differ-
ences in the frequency of psychiatric comorbidities between 
male and female patients (χ2=0.73, df =1, P=0.391); however, 
male patients (67.13%) had more often somatic comorbidities 
(χ2=8.52, df =1, P=0.0035) than female patients (52.63%).
As shown in Table 1, alcohol-dependent subjects enrolled 
in the study had more often late (64.93%) rather than early 
(35.07%) onset of alcohol abuse. However, we observed 
significantly lower frequency of female patients with early, 
rather than with late, onset of alcohol abuse in comparison 
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Table 2 genotype and allele counts and frequencies of rs13212041 HTR1B gene polymorphism in alcohol-dependent patients 
subdivided according to the gender and early/late onset of alcohol abuse
HTR1B SNP Genotype N (%) Statistics Allele N (%) Statistics
rs13212041 CC CT TT df =2 C T df =1
Males, N (%) 21 (4.21) 157 (31.46) 321 (64.33) χ2=2.135, P=0.344; 
χ2-test
199 (19.94) 799 (80.06) χ2=1.977, P=0.160; 
χ2-testFemales, N (%) 6 (5.26) 43 (37.72) 65 (57.02) 55 (24.12) 173 (75.88)
early onset of alcohol abuse, N (%) 16 (7.44) 65 (30.23) 134 (62.33) χ2=7.539, P=0.023; 
χ2-test
97 (22.56) 333 (77.44) χ2=1.366, P=0.243; 
χ2-testlate onset of alcohol abuse, N (%) 11 (2.76) 135 (33.92) 252 (63.32) 157 (19.72) 639 (80.28)
with male subjects (χ2=15.30, df =1, P,0.0001). Moreover, 
there were significantly more smokers in the group of early-
onset alcoholics than in subjects with late onset of alcohol 
abuse (χ2=6.94, df =1, P=0.008). There were no significant 
differences in the frequency of somatic comorbidities 
(χ2=3.47, df =1, P=0.062) or liver diseases (χ2=3.31, df =1, 
P=0.069) between patients with early and late onset of alco-
hol abuse. However, early onset alcohol-dependent subjects 
more often had psychiatric comorbidities (52.09%) than 
patients with late onset alcohol abuse (41.96%) (χ2=5.78, 
df =1, P=0.016), although they did not differ in frequency 
of depression (χ2=0.51, df =1, P=0.477) (Table 1).
Genotype distributions for rs13212041 HTR1B polymor-
phism in alcohol-dependent subjects were in HWE (χ2=0.03, 
P=0.866). No significant differences in the frequency of the 
genotypes (χ2=2.13, df=2, P=0.344) or alleles (χ2=1.98, 
df =1, P=0.160) between male and female alcohol-dependent 
patients were detected using χ2-test (Table 2); therefore, in 
further analysis, patients were not divided according to gender. 
The genotype distribution for HTR1B gene polymorphism 
was significantly different (χ2=7.54, df =2, P=0.023) between 
patients with early and late onset of alcohol abuse (Table 2). 
Namely, the individuals carrying the CC genotype were 
significantly more frequent (χ2=7.25, df =1, P=0.007) in the 
group of alcohol-dependent subjects with early onset of alco-
hol abuse than in carriers of T allele. This strong evidence of 
HTR1B was also confirmed using multiple regression analysis 
(P=0.024), with age (P,0.0001) and gender (P=0.001) as 
major variables influencing the onset of alcohol abuse.
As recent analysis suggested that the early onset of 
alcohol dependence is best defined as beginning before the 
age of 22 years,5 we additionally divided alcohol-dependent 
patients into subjects with early and late onset of alcohol 
abuse by using cut-off point at 22 years. Although the num-
ber of patients with early onset of alcohol abuse was, in this 
case, significantly lower (N=107), the results obtained after 
making cut-off at 22 years supported and even strengthened 
the findings obtained with cut-off at 25 years. Both the 
genotype (χ2=12.07, df=2, P=0.0024) and allele (χ2=8.456, 
df=1, P=0.0036) distribution for HTR1B gene polymorphism 
was significantly different between patients with early and 
late onset of alcohol abuse. Namely, the individuals car-
rying the CC genotype (χ2=10.63, df =1, P=0.0011) or C 
allele (χ2=4.269, df =1, P=0.0388) were significantly more 
frequent in the group of alcohol-dependent subjects with 
early onset of alcohol abuse than in carriers of the T allele 
or TT genotype, respectively.
Platelet 5-HT concentrations (mean±SD) were not sig-
nificantly different between male (0.84±0.49) and female 
(0.75±0.46) alcohol-dependent subjects (U=25795, df =611, 
P=0.121; Mann–Whitney test). Moreover, the Kruskal–Wallis 
test failed to detect any significant differences in platelet 
5-HT concentration between carriers of CC (0.84±0.46), 
CT (0.79±0.48), or TT (0.84±0.48) HTR1B rs13212041 
genotypes, in the whole sample of alcohol-dependent patients 
(H=1.556, df=610, P=0.459), as well as when alcohol-
dependent patients were subdivided into subjects with early 
and late onset of alcohol abuse (H=6.643, df =607, P=0.249).
Significant differences in platelet 5-HT concentrations 
were found between alcohol-dependent patients with early 
(0.88±0.48) and late (0.79±0.48) onset of alcohol abuse 
(U=38035, df=611, P=0.023; Mann–Whitney test; Table 1), 
and when these patients were additionally subdivided accord-
ing to smoking status (H=36.49, df =609, P,0.0001; 
Kruskal–Wallis ANOVA; Figure 1). However, as shown in 
Figure 1, the results of post-hoc Dunn’s multiple comparison 
test revealed significant differences only between smokers 
and nonsmokers, both in the group with early (P=0.0004) 
and late (P=0.0005) onset of alcohol abuse, suggesting an 
effect of smoking on platelet 5-HT concentration. There were 
no significant differences in platelet 5-HT levels between 
smokers with early and late onset of alcohol abuse (P=0.309) 
or between nonsmokers with early and late onset of alco-
hol abuse (P.0.9999) (Dunn’s multiple comparison test; 
Figure 1). Multiple regression analysis also confirmed that 
there was no association of platelet 5-HT levels (P=0.104) 
with the onset of alcohol abuse. Therefore, observed 
differences in platelet 5-HT concentrations between alcohol-
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dependent patients with early and late onset of alcohol abuse 
were probably due to higher frequency of smokers in the 
group of alcoholics with early onset of alcohol abuse.
Our findings also suggested that there was significant 
difference in the smoking frequency between alcohol-
dependent subjects with and without comorbid depres-
sion (χ2=6.71, df=1, P=0.0096; χ2-test). Namely, 81.82% 
of alcohol-dependent subjects with comorbid depression 
were smokers in comparison with 59.14% smokers in 
the group of alcoholic patients without comorbid depres-
sion. However, there was no significant difference in the 
frequency of comorbid depression between patients with 
early and late onset of alcohol abuse (Table 1), as well as 
no significant difference in the platelet 5-HT concentration 
between alcohol-dependent subjects with (0.94±0.57) and 
without (0.81±0.48) comorbid depression (U=8368, df=611, 
P=0.2257; Mann–Whitney test). In general, we observed 
no significant differences in platelet 5-HT concentration 
between alcohol-dependent patients with and without psy-
chiatric (U=45371, df=611, P=0.576; Mann–Whitney test) as 
well as somatic comorbidities (U=42972, df=611, P=0.969; 
Mann–Whitney test).
Finally, multiple regression analysis demonstrated no sig-
nificant influence of age (P=0.632), gender (P=0.270), onset 
of alcohol abuse (P=0.157), HTR1B rs13212041 genotype 
(P=0.473), somatic (P=0.584), and psychiatric comorbidi-
ties (P=0.993), but significant effect of smoking (P,0.0001) 
on platelet 5-HT concentration in patients with alcoholism.
Discussion
The main finding of our study is an association of rs13212041 
HTR1B gene polymorphism with an onset of alcohol abuse in 
alcohol-dependent patients, demonstrating that homozygous 
individuals with CC genotype were more frequent in the 
group with early onset of alcohol abuse compared to carri-
ers of T allele. Besides HTR1B genotype, age and gender, 
but not platelet 5-HT, were major variables influencing the 
onset of alcohol abuse. Platelet 5-HT concentration was not 
significantly different between subjects with early and late 
onset of alcohol abuse as well as between patients carry-
ing different HTR1B genotypes. Although we observed no 
influence of co-variables such as age, gender, or somatic and 
psychiatric comorbidities, platelet 5-HT concentration was 
significantly affected by smoking.
Only few studies investigated the association of 
rs13212041 HTR1B gene polymorphism with alcohol 
dependence,41,42 but not with early- and late-onset alcoholism 
subtypes. This transition substitution (A1997G) in the distal 
3′-untranslational region (UTR) of HTR1B messenger RNA 
disrupts a binding site for the microRNA, miR-96.40 MiR-96 
is expressed in the brain,59 and various environmental factors, 
such as stress,60 can modulate its expression and epigeneti-
cally underlie some of the diversity in human behavior,40 
including alcoholism endophenotypes. As A-allele carriers 
of rs13212041 HTR1B gene polymorphism demonstrate 
reduced HTR1B expression compared to G-allele carriers,40 
we can presume that subjects with early onset of alcohol 
abuse, more frequently carrying the CC genotype, have 
higher levels of 5-HT1B receptors than patients with late 
onset of alcohol abuse.
In general, alcohol dependence has been associated with 
increased density of 5-HT1B receptors in specific brain 
regions.61 5-HT1B receptors have been shown to modify the 
effects of alcohol and regulate its voluntary intake,62 whereas 
5-HT1B receptor ligands reduce extensive alcohol drink-
ing and alcohol-related aggressive or impulsive behavior, 
observed in more severe forms of alcohol dependence.31,63 
Therefore, our findings might suggest increased expression 
of 5-HT1B receptors in more severe types of alcoholism, 
characterized with an early onset of alcohol abuse.
Our results demonstrating that early onset alcohol-
dependent patients more often have psychiatric comorbidities 
agree with findings that these subjects have more alcohol-
related problems, more severe symptoms, and higher rates of 
somatic and psychiatric comorbidity.4,10 In our study, besides 
HTR1B genotype, age and gender were major variables 
influencing the onset of alcohol abuse. This is not surpris-
ing as male patients were younger and more often present in 
the group with an early onset of alcohol abuse, in line with 
suggestions that type II alcoholism is male predominant.7
(DUO\RQVHWDOFRKRODEXVH3ODWHOHW+7
FRQFHQWUDWLRQ QPR/PJSURWH
LQ


  
/DWHRQVHWDOFRKRODEXVH
1RQVPRNHUV6PRNHUV
Figure 1 Platelet 5-hT concentration in alcohol-dependent smokers and 
nonsmokers subdivided according to the early/late onset of alcohol abuse.
Note: *P,0.0005 smokers vs nonsmokers (Kruskal–Wallis test and post-hoc 
Dunn’s multiple comparison test).
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The HTR1B rs13212041 polymorphism, by influencing 
5-HT1B receptor expression, can subsequently affect 5-HT 
turnover. Namely, 5-HT1B receptors function as inhibitory 
autoreceptors or heteroreceptors on both serotonergic and 
non-serotonergic neurons, and modulate serotonergic activ-
ity. However, despite presumably higher density of 5-HT1B 
receptors in early-onset alcoholics, platelet 5-HT concentra-
tions did not differ between patients with early and late onset 
of alcohol abuse, suggesting no association of platelet 5-HT 
with the onset of alcohol abuse.
Many components of serotonergic system, such as 
5-HTT, MAO, and some 5-HT receptors, in both platelets 
and neurons are encoded by the same genes and have similar 
structural and functional properties.52,53 However, the role of 
5-HT1B receptors might differ depending upon their specific 
location.64 In addition, activation of presynaptic 5-HT1B 
receptors inhibits 5-HT release, while 5-HT1B postsynaptic 
heteroreceptors are involved in the modulation of addictive 
behaviors.65 Therefore, platelet 5-HT1B receptors might not 
regulate 5-HT concentration in platelets, or their function 
could be affected by other 5-HT receptors66,67 or interac-
tion with 5-HTT.68 No differences in platelet 5-HT levels, 
between carriers of different HTR1B rs13212041 genotypes 
in all alcohol-dependent patients, as well as in subjects with 
early and late onset of alcohol abuse, suggest that this poly-
morphism does not influence platelet 5-HT concentration.
Although previous studies found decreased platelet 5-HT 
concentration in alcohol-dependent subjects,69–71 only one 
small study reported higher platelet 5-HT uptake in subjects 
with early than with late-onset of alcohol dependence, sug-
gesting differences in platelet 5-HTT function.72 However, 
in this study as well as these in many other studies, somatic 
and psychiatric comorbidities and tobacco smoking have 
been neglected as confounding factors, in spite of reports 
suggesting their effects on platelet 5-HT.49,73 We observed no 
significant influence of somatic and psychiatric comorbidi-
ties, including depression, but smoking significantly affected 
platelet 5-HT levels in alcohol-dependent patients in our 
present and previous study.74 In agreement with previous 
results,71 we detected higher platelet 5-HT concentrations in 
smoking alcoholics than in alcohol-dependent subjects who 
did not smoke. Patkar et al75 reported correlation of smok-
ing with decreased density of platelet 5-HTT sites, whereas 
various studies reported metabolic effects of smoking on the 
breakdown of dopamine and 5-HT,76,77 as well as decreased 
platelet MAO-B activity due to cigarette smoking.78,79
In addition to appropriate sample size and statistical 
power, other advantages of this study include ethnically 
homogenous and medication-free alcohol-dependent patients 
and carefully determined specific alcohol-related pheno-
types, including somatic and psychiatric comorbidities and 
other potential confounding factors such as age, gender, and 
smoking. However, one of the study limitations is a lack of 
replication of obtained results in the independent sample.
Conclusion
As far as we know, this is the first study reporting the asso-
ciation of rs13212041 polymorphism, located in the HTR1B 
gene coding for 5-HT1B receptor, with the onset of alcohol 
abuse in alcohol-dependent subjects. Our results suggest that 
homozygous individuals with CC genotype are more likely 
to develop a more severe form of alcoholism, characterized 
by the early onset of alcohol abuse, than carriers of T-allele. 
As rs13212041 polymorphism affects microRNA regula-
tion of HTR1B gene expression, these data might suggest 
the involvement of epigenetic mechanisms in the modula-
tion of serotonergic functions in alcohol dependence. Our 
findings might provide novel insights in the serotonergic 
regulation mechanisms underlying the early/late onset of 
alcohol abuse, which could help in further differentiation 
of alcoholism subtypes and potential improvement of the 
therapy for this complex disease. The results of our study 
also emphasize the importance of controlling for various 
confounding factors, such as smoking, which significantly 
influence platelet 5-HT levels.
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